Technology
& Custom assays
ViQi’s Optimized System
To achieve speed, rigor and compliance with your customer assays - we’ve created a “system” that includes control based Auto-Machine Learning, Platform, Validation & Compliance
Ensuring that every assay is as secure as it is effective.
At ViQi we believe that imaging cells and tissues unlocks a vast untapped potential to improve and optimize the entire drug development pipeline. Data analysis is the current bottleneck for this reality. To this goal, we have designed a builder for predictive AI assays that dramatically simplifies the assay automation process. Compliance is woven into every assay, ViQi’s platform is designated as FDA Class I Medical Device Data System (MDDS) and is ISO27001 certified.
ViQi’s proprietary SaaS platform operationalizes automatic assay building which enables the processing of terabytes of data with high precision.
Predictive AI
ViQi’s AI-driven engine enables precision and speed, turning complex data into actionable results that align with your unique objectives.
Our assays follow a proprietary Phenotypically Targeted AI (PTA™) approach which automates and operationalizes predictive AI assays. With our innovative system, each tool is crafted to help you do more faster and with increased accuracy, paving the way for groundbreaking advancements in process and analytical development in bioprocessing & diagnostic industries.
Examples our Phenotypically Targeted AI can address:
Lack of a clear biological marker or reporter to understand underlying mechanisms.
Manual cell or colony counting, which is prone to human error and time-consuming.
Difficulty in predicting the toxicity of new drug candidates.
Existing assays that are often:
–Too slow
–Unable to handle high sample volumes
–Insensitive
And more–The list is limitless.
Bioassay Development –faster and more accurate.
ViQi’s Platform
ViQi’s platform, VQDS, functions as a powerful, adaptable workbench, where advanced AI capabilities and robust imaging technologies come together to build custom assays tailored to specific research needs.
Serving as a centralized, cloud-based hub, the ViQi platform provides all the tools required to develop, validate, and refine AI-driven assays with precision and efficiency.
It supports vast data management and high-throughput image analysis, enabling seamless integration and collaboration across teams. This workbench approach ensures that scientists can quickly create, test, and optimize assays, all within a secure, compliant environment. By simplifying complex assay development workflows, ViQi’s platform accelerates the journey from data collection to actionable insights, empowering CDMOs, CROs, and biomanufacturers to push the boundaries of the most impactful workflows.
Validation Tools
At ViQi, compliance and validation are foundational, ensuring our AI-driven platform meets the highest regulatory standards. As a designated FDA Class I non-device MDDS, our ISO27001 certified platform embeds quality, safety, and data security in every assay. We work with our customers to rigorously validate each assay per ICH standards for reliable, reproducible results across a variety applications.
ViQi’s commitment to security and rigor ensures life science companies can confidently use ViQi’s solutions, knowing their data is both scientifically sound and compliant with regulatory requirements—driving faster, reliable advancements in analytical and process development and QC assay validation.
Process
Achieve your goals faster and with more efficiency with our proven, simple process.
